Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN) a phase 3, randomised, double-blind, placebo-co...

Howard James F., Utsugisawa Kimiaki, Benatar Michael, Murai Hiroyuki, Barohn Richard J., Illa Isabel, Jacob Saiju, Vissing John, Burns Ted M., Kissel John T., Muppidi Srikanth, Nowak Richard J., O'Brien Fanny, Wang Jing-Jing, Mantegazza Renato, Vécsei László
2017

Post-intervention status in patients with refractory myasthenia gravis treated with eculizumab during regain and its open-label extension

Mantegazza Renato, Wolfe Gil I., Muppidi Srikanth, Wiendl Heinz, Fujita Kenji P., O'Brien Fanny L., Booth Heather D. E., Howard James F., Mazia Claudio Gabriel, Wilken Miguel, Barroso Fabio, Vécsei László, Dézsi Livia, Varga Edina Tímea, Rózsa Csilla
2021